Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and ...

Rep. Nancy Pelosi (D-Calif.) had a hip replacement after sustaining an injury while traveling earlier this week, according to a statement from her office. “Earlier this morning, Speaker Emerita Pelosi ...

The most interesting club in the Premier League trio after the Barca man is Liverpool, given he could be a like-for-like replacement for Mohamed Salah, whose future remains up in the air ...

Representative Nancy Pelosi, Democrat of California, underwent hip replacement surgery today following a tumble she took while on an official trip to Luxembourg Friday. While details were scant ...

Former House Speaker Nancy Pelosi had hip replacement surgery Saturday at a U.S. military hospital in Germany after falling while at an event in Luxembourg with other members of Congress. Pelosi, 84, ...

Former House Speaker Nancy Pelosi underwent a successful hip replacement surgery after she was injured on a congressional delegation trip in Luxembourg. NBC News' Gary Grumbach reports on how ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other income stocks. When it comes to income investing, dividend stocks are often the ...

The New York Mets have won the free agency prize in signing Juan Soto, but continue to be linked to more upper echelon free agents this offseason. Ari Alexander of KPRC2 Houston reported that the ...

On Friday, Eli Lilly And Co (LLY) stock saw a modest uptick, ending the day at $789.12 which represents a slight increase of $6.77 or 0.87% from the prior close of $782.35. The stock opened at $777.13 ...

We recently compiled a list of the 16 Best Income Stocks To Buy According to Analysts. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other ...

Eli Lilly (NYSE:LLY) has received a positive recommendation for approval from European regulators for its drug Omvoh in the treatment of Crohn’s disease. The European Medicines Agency's ...